as on February 20, 2026 at 9:31 pm IST
52 Week's Low
52 Week's High
25.85%
Downside
28.29%
Upside
as on February 20, 2026 at 4:01 pm IST
Market Cap
₹131.22 Cr
Return on Equity (ROE)
9.42
PE Ratio (TTM)
29.32
Return on capital employed (ROCE)
11.41
Industry PE ratio
41.52
Beta (LTM)
1.05
P/B Ratio
2.47
Dividend Yield
0PEG Ratio
49.7
Quarterly Earnings Growth YOY
100
EPS (TTM)
8.39
Sector
Pharmaceuticals
Book Value
48.19
as on February 20, 2026 at 4:01 pm IST
Sotac Pharma in the last 5 years
Lowest (13.14x)
April 24, 2023
Today (29.32x)
February 18, 2026
Industry (41.52x)
February 18, 2026
Highest (44.90x)
July 16, 2024
Today’s Price to Earnings Ratio: 29.32x
Compare market cap, revenue, PE, and other key metrics of Sotac Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 131.22 | -0.33% | 0.74 | 9 | 96 | |
| NA | 223.70 | 110.15% | 0.00 | 2 | 386 | |
| NA | 428.72 | -8.55% | 0.57 | 6 | 162 | |
| NA | 20.38 | -8.1% | 0.00 | 2 | 33 | |
| NA | 164.11 | 19.79% | 0.68 | 5 | 169 |
Search interest for Sotac Pharmaceuticals Ltd Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:6% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Sotac Pharma .
Sotac Pharmaceuticals Ltd’s net profit fell -29.23% since last year same period to ₹0.46Cr in the Q2 2024-2025. On a quarterly growth basis, Sotac Pharmaceuticals Ltd has generated -68.28% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Sotac Pharmaceuticals Ltd has declared dividend of ₹0.10 per share on 28 May 2025 - translating a dividend yield of 0.08%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
![]()
Foreign Institutions have increased holdings from 15.12% to 16.14% in Sep 2025 quarter
Price Rise
![]()
In the last 1 month, SOTAC stock has moved up by 13.1%
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 25.5 Cr → 27.8 Cr (in ₹), with an average increase of 8.3% per quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 72.85% of holdings in Sep 2025 quarter
Profit Down
![]()
Netprofit is down for the last 3 quarters, 1.64 Cr → 0.46 Cr (in ₹), with an average decrease of 39.9% per quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 11.35% to 11.01% in Sep 2025 quarter
| Organisation | Sotac Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| CEO | Sharadkumar Dashrathbhai Patel |
| E-voting on shares | Click here to vote |
Sotac Pharma share price today stands at ₹118.75 as on at the close of the market. Sotac Pharma share today touched a day high of ₹118.75 and a low of ₹118.75.
Sotac Pharma touched a 52 week high of ₹152.35 and a 52 week low of ₹88.05. Sotac Pharma share price today i.e. is closed at ₹118.75, which is -22.05% down from its 52 week high and 34.87% up from its 52 week low.
Sotac Pharma market capitalisation is ₹131.22 Cr as on .
To buy Sotac Pharma shares, you need to follow these steps:
Sotac Pharma trading volume is 0.00 as on . This means that 0.00 shares of Sotac Pharma were bought and sold on the stock market during today's trading session.